ITC Ltd. recorded a substantial block trade on the National Stock Exchange (NSE), with approximately 2,859,363 shares changing hands in a single transaction. The deal, valued at Rs. 92.96 crores, was executed at Rs. 325.10 per share, highlighting significant institutional trading activity in the stock.

Block Trade Details

The transaction represents a notable movement in ITC shares, with the following key parameters:

Market Significance

Block trades are typically executed when large institutional investors, mutual funds, or other significant market participants need to buy or sell substantial quantities of shares. These transactions are conducted outside the regular market to avoid impacting the stock's market price through large volume trades.

The execution of this block trade at Rs. 325.10 per share indicates the price level at which institutional participants were willing to transact in ITC shares. Such transactions often reflect portfolio rebalancing activities, strategic investments, or divestments by large investors.

Trading Activity

The substantial value of Rs. 92.96 crores involved in this single transaction underscores the scale of institutional interest in ITC shares. Block trades of this magnitude typically involve sophisticated investors and can provide insights into institutional sentiment toward the stock.

This trading activity demonstrates the continued institutional participation in ITC, one of India's prominent consumer goods and cigarette manufacturing companies, reflecting ongoing investor interest in the stock despite various market conditions.

ITC Limited has announced key changes to its Board of Directors, with the appointment of a new Non-Executive Director and the resignation of an existing board member, both effective from April 1, 2026.

Board Appointment Details

The Board of Directors, in their meeting held on January 29, 2026, has recommended the appointment of Mr. Navin Agarwal as a Non-Executive Director. The appointment details are structured as follows:

The appointment is subject to approval by the company's members and represents SUUTI's continued involvement in the company's governance structure.

Director Resignation

Concurrently, Dr. Alok Pande has submitted his resignation from the Board of Directors, marking the end of his tenure as a Non-Executive Director representing SUUTI. The resignation details include:

Dr. Pande expressed gratitude for his tenure on the Board and extended his appreciation to the leadership and fellow board members for their guidance and cooperation during his service.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The changes have been formally communicated to:

• National Stock Exchange of India Ltd.
• BSE Ltd.
• Securities Exchange Commission, Washington DC
• Societe de la Bourse de Luxembourg

The communication was signed by R. K. Singhi, Executive Vice President & Company Secretary, and includes Dr. Pande's resignation letter as required documentation.

Transition Timeline

The seamless transition is scheduled for April 1, 2026, ensuring continuity in SUUTI's representation on the Board. This change reflects the ongoing governance practices and stakeholder management within the company's corporate structure.